As deepening healthcare forays by tech and e-commerce giants ratchet up the pressure on pharma to become more consumer friendly, drugmakers are still defining their new role.
Specialist media consulting firms and media agencies have claimed Accenture faces a "clear conflict" of interest over the launch of its programmatic media planning and buying unit.
Nanobiosym hired the agency shortly after its proprietary technology was approved by the FDA.
Genevieve Paquette is chief marketing officer and board member of Level Ex.
Kathy Delaney is chief creative officer of Publicis Health.
Becky Chidester is CEO of Wunderman Health.
Neera Chaudhary is global president of healthcare of Golin.
Shaun Qualheim from Amazon Web Services explained how the company's small teams and customer-first and failure-friendly culture promotes innovation.
Experts on using technology to change patient behavior and other topics.
Digital health experts discussed how tech is disrupting the healthcare industry at the MM&M Transforming Healthcare conference.
At the Asembia Specialty Pharma summit, speakers described a healthcare ecosystem in which specialty products will represent nearly half of all drug spending.
The former WPP chief executive shared his view on technology, the economy, and politics on Tuesday at Techonomy NYC 18.
Marketers discuss the role of ad safety tech in helping pharma clients feel comfortable with ads in non-endemic media.
Record year for brands, fewer celebrities, lower volume of entries expected and much more.
Those on the vanguard of transformation include a number of upstarts and veteran gurus taking on historic challenges plaguing health data.
Here are the 40 upstarts and veterans who are transforming the healthcare industry.
Kevin Johnson is president of Marketeching.
Susan Dorfman is chief commercial officer of CMI/Compas.
Justin Chase is EVP and head, innovation and media at Intouch Solutions.
Anne Weiler is CEO and cofounder of Wellpepper.
Tej Toor was formerly product at Blink Health.
Sandra Shpilberg is founder and CEO of Seeker Health.
Scarlet Shore is product manager and platform lead, Project Baseline at Verily.
Omri Shor is CEO of Medisafe.
Sanjeev Saxena is CEO of POC Medical Systems.
Camille Samuels is partner of Venrock.
Colleen Reinhart is director, patient marketing and therapy awareness, transcatheter heart valves at Edwards Lifesciences.
Joe Meadows is president of Think Patients.
Chrissa McFarlane is founder and CEO of Patientory.
Molly McCarthy is national director, U.S. provider market and chief nursing officer of Microsoft.
Eddie Martucci is CEO of Akili Interactive Labs.
Missy Krasner is special projects/disruptive innovation at Amazon.
William King is founder and executive chairman of Zephyr Health.
John Jorden is executive director, Amgen Digital Health at Amgen.
Aaron Horowitz is cofounder and CEO of Sproutel.
Pablo Graiver is CEO of Antidote.
Jamey Edwards is CEO of Cloudbreak Health.
David Ebersman is cofounder and CEO of Lyra Health.
Nick Desai is cofounder and CEO of Heal.
Jeffrey Brewer is cofounder, president, and CEO of Bigfoot Biomedical.
Sundeep Bhan is cofounder and CEO of Prognos.
Jay Appel is executive director of Bristol-Myers Squibb.
Is technology causing agencies to become more specialized? Is there still a need for the human connection?
A deal with Sandoz to lead the global launch of Pear's two lead products puts marketing muscle behind the nascent class of 'prescription digital therapeutics.'
The Facebook CEO did not wilt during this week's marathon Senate session.
Despite the US Congress's lack of insight into Facebook's operations, Mark Zuckerberg's handling of the situation seems to have restored investor confidence in the company.
Scott Dulitz, SVP, Corporate Strategy, Business Development for TrialCard, outlines how embracing the modern hub allows brands to reach their full potential.
She will lead Nuvo Group's U.S. operations and head marketing globally.
With healthcare evolving from a fee-for-service system toward one that bases payment on outcomes, marketers must speak to customers in value-oriented messages.
AI, wearables, and VR still reign supreme in the healthcare realm, and other things you missed
Caregivers and patients predict how the use of AI will affect them.
Philip Thomas takes over from Terry Savage.
AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practice
The potential is real, but companies and technology gurus often speak of machine learning as a catch-all solution. The hype may be slowing AI's incremental growth in healthcare, experts say.
MM&M has announced its annual showcase of executives, investors, entrepreneurs, designers and thinkers who are ushering the industry into its new technological golden era.
MM&M spoke with Gazzaley about what's next for Akili, how he defines "digital medicine," and where the field is currently positioned on the hype cycle.
Want to get an ethicist agitated? Mention the integration of voice-activation and other tech into healthcare. Experts say navigating this area is a work in progress.
Health's popularity at SXSW continues to build. Here's our opening weekend wrap-up.
Recently, Forbes ran an article from Wild Pixel Media founder and CEO Carlos Machicao lamenting the fact that healthcare advertising is boring.
Acquisitions that were applauded a few years ago, such as Teva's purchase of Allergan's generic business, now look like lemons.
From Muse: Michelle Obama on making consumers comfortable with med tech (and thinking before she tweets)
The former first lady spoke at Klick Health's Muse event, which also featured panels on gene therapy, health technology, and immunotherapy.
Heal CEO Nick Desai aims to improve the patient experience by providing an on-demand service that cuts time and costs while increasing human interaction.
Boston Children's Hospital and Klick Health are unveiling a VR tool to help pediatric patients visualize their disease and symptoms. It could augment the paper-based standard of care.
The platform is looking to focus its communications strategy on the U.S. market.
Virta Health CEO Sami Inkinen on changing patient behavior: 'We're cutting down trees in the wrong forest'
Seven questions for the Virta Health chief executive and cofounder of Trulia.
For some, the term machine learning may conjure up images of virtual assistants or automated tools.
Zimprich joins from Honeywell, where he led global business communications.
By allowing companies to claim a 50% tax credit for qualified clinical testing expenses, developing drugs for rare diseases became economically feasible for the first time.
Fueled by system-wide demand and facilitated by AI, the industry's lofty expectations around real-world evidence could soon be fulfilled
Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say
Details are vague, but the e-commerce giant indicated it's serious about getting into healthcare.
Somatix is a digital health platform that tracks movements through smartwatches.
In his first press conference as president-elect, Donald Trump insisted pharma was "getting away with murder" due to expensive drug prices.
Some microinfluencers see the latest YouTube guidelines as a "slap in the face."
Advertisers have until July to get their mobile pages up to speed.
Celgene reportedly in talks to buy Juno; Novartis' Kymriah receives fast-track reviews in U.S. and Europe; BI's Gilotrif gets expanded approval in lung cancer
The tech that's most likely to survive post-CES hype is voice but brands should rethink their gendered approach.
New research calls into question the behavioral effects of some digital health tools.
Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations
Maker of Botox biosimilar Evolus files IPO; pharma execs expect major acquisitions in 2018; J&J and Bayer win Xarelto reversal verdict
In the absence of behemoths such as Facebook and Twitter, pharma is partnering with China's tech giants to snare a slice of a more than $100 billion market
MM&M is calling for nominations for the 2018 class of Top 40 Healthcare Transformers and is seeking industry input for the Top 10 Innovation Catalysts.
As HCPs continue to be stretched for time to diagnose and interact with patients, health bots could help reduce HCP workload and drive patient engagement.
US bank JPMorgan Chase has returned to advertising on YouTube only after developing its own algorithm that ensures its ads are not placed around questionable content.
Digital innovation in Japan, health-tech trends, and social media top the list.
Mallinckrodt to buy Sucampo for $1.2 billion; Amazon pushes digital advertising in 2018; WHO classifies gaming disorder as mental health condition
From gift bans to Google Assistant, POC to OPDP, MM&M staff members give their predictions on what to expect in healthcare marketing in 2018
Pharma R&D return on investment falls to eight-year low; FDA approves Pfizer's biosimilar to J&J's Remicade; Novartis to downsize generics business
It turns out the real goal is going after Washington's favorite whipping boy — high drug prices.
The digital health startup was founded in 2015.
FDA approves first nebulized LAMA COPD treatment; more than 2,000 cancer immunotherapies in development; FDA issues 3D-printing guidance
DeVine will oversee the agency's health IT and medical device work.
Lighthouse received $50,000 for application aimed at providing more accessible and engaging care for those living with diabetes.
Next year will be the start of the shift from marketing algorithms to AI, predicts Kantar Millward Brown.
Innovation-minded executives share their thoughts and predictions for the year ahead.
Botox-like wrinkle-reducer shows positive results in trials; investors double down on fertility; few websites transparent about pricing, study finds
GroupM, the media investment arm of WPP, forecasts global ad growth of 4.3% in 2018, and predicts Google and Facebook will strengthen their stranglehold on digital advertising.
CVS to buy Aetna for $69 billion; J&J buys commercial rights for biotech's experimental hypertension drug; Republicans repeal Obamacare's individual mandate
FDA approves first Apple Watch health accessory; medical charity shared data with pharma donors; FDA approves opioid-addiction treatment
FDA releases information on Exondys 51; Sanofi's dengue vaccine faces new restrictions; Kellyanne Conway named opioid czar